NEPHROS INC (NEPH)

↓ Download CSV

CIK 0001196298 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, NEPHROS INC reported revenue of $18.79M, up 32.7% from the prior year. The company was profitable, with a net margin of 6.4% and a gross margin of 61.9%. It held $13.64M in total assets against $3.44M in total liabilities.

Key ratios (FY2025)

61.9%
Gross margin
6.1%
Operating margin
6.4%
Net margin
11.7%
Return on equity
+32.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$18.79M$14.16M$14.24M$9.97M$10.22M$8.56M$10.33M$5.69M$3.81M
Cost of Revenue$7.16M$5.44M$5.83M$5.24M$4.58M$3.65M$4.25M$2.48M$1.52M
Gross Profit$11.62M$8.72M$8.40M$4.73M$5.63M$4.91M$6.08M$3.20M$2.29M$1.29M
Operating Income$1.15M$6.0K-$1.59M-$4.33M-$3.25M-$4.28M-$3.15M-$3.02M-$2.23M-$2.87M
Net Income$1.19M$74.0K-$1.57M-$3.87M-$4.53M-$3.18M-$3.40M-$809.0K-$3.03M
EPS (Diluted)$0.11$0.01$-0.15$-0.73$-0.41
Total Assets$13.64M$11.21M$11.86M$11.00M$17.65M$18.51M$11.63M$10.56M$4.98M$2.68M
Total Liabilities$3.44M$2.62M$3.50M$2.12M$2.90M$2.94M$3.94M$3.76M$3.03M$2.01M
Shareholders' Equity$10.20M$8.59M$8.36M$8.88M$14.75M$15.57M$7.69M$6.80M$1.95M$667.0K
Cash & Equivalents$5.40M$3.76M$4.31M$3.63M$6.97M$8.25M$4.17M
Operating Cash Flow$1.60M-$500.0K-$77.0K-$2.11M
Capital Expenditures$55.0K$75.0K$137.0K$36.0K$239.0K$14.0K$45.0K
Shares Outstanding10.64M10.54M10.54M10.30M10.26M9.87M8.06M7.18M55.29M49.78M